Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Recruiting 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2

Conditions

Glioblastoma 1Brain Neoplasms 1

Interventions

Specimen Handling 198Magnetic Resonance Spectroscopy 160pembrolizumab 141Carboplatin 117Biopsy 111Cyclophosphamide 93Cisplatin 93Paclitaxel 75Bevacizumab 61Gemcitabine 60Nivolumab 57fludarabine 53Radiotherapy 50Fluorouracil 49Pemetrexed 46Oxaliplatin 43Dexamethasone 43venetoclax 42Rituximab 41Leucovorin 41Doxorubicin 41durvalumab 40Docetaxel 40Capecitabine 39Radiation 37atezolizumab 35Prednisone 32Injections 31Fulvestrant 31Standard of Care 29

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Recruiting × Valacyclovir × 30 days × Clear all
NCT06914479 2026-05-27

Virus-Based Gene Therapy (AdV-HSV1-TK and AdV-Flt3L) in Combination With Valacyclovir for the Treatment of Pediatric and Young Adult Patients With Resectable, Recurrent Primary Malignant Brain Tumors

University of Michigan Rogel Cancer Center

Phase 1 Recruiting
11 enrolled
CNS

Brain Neoplasms

NCT07346144 2026-05-04

ADePT

Trogenix ltd

Phase 1/2 Recruiting
68 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡